Human Recombinant BRAK (from E. coli)

Supplier: Peprotech

300-50-5UG 300-50-20UG 300-50-100UG 300-50-250UG 300-50-500UG 300-50-1MG
10770-738EA 221.44 CAD
10770-738 10770-740 10770-742 10770-744 10770-746 10770-748
Human Recombinant BRAK (from E. coli)
Proteins and Peptides

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant Human BRAK (CXCL14) is a 9.4 kDa protein containing 77 amino acid residues.


Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR